These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12121125)

  • 1. Peptide arrays for highly sensitive and specific antibody-binding fluorescence assays.
    Melnyk O; Duburcq X; Olivier C; Urbès F; Auriault C; Gras-Masse H
    Bioconjug Chem; 2002; 13(4):713-20. PubMed ID: 12121125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a time-resolved fluoroimmunoassay for Epstein-Barr virus viral capsid antigen IgA antibody in human serum.
    Liang QN; Chen PQ; Liu TC; Zhou JW; Chen JJ; Wu YS
    J Virol Methods; 2015 Sep; 222():16-21. PubMed ID: 25977184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-protein microarrays for the simultaneous detection of pathogen infections.
    Duburcq X; Olivier C; Malingue F; Desmet R; Bouzidi A; Zhou F; Auriault C; Gras-Masse H; Melnyk O
    Bioconjug Chem; 2004; 15(2):307-16. PubMed ID: 15025526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.
    Chen JJ; Liu TC; Liang QN; Dong ZN; Wu YS; Li M
    J Med Virol; 2015 Nov; 87(11):1940-5. PubMed ID: 26129643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay.
    Hopkins RF; Witmer TJ; Neubauer RH; Rabin H
    J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection.
    Casey JL; Coley AM; Street G; Parisi K; Devine PL; Foley M
    J Clin Microbiol; 2006 Mar; 44(3):764-71. PubMed ID: 16517852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of virus-specific immunoglobulin M (IgM), IgG, and IgA antibody detection with a polyantigenic enzyme-linked immunosorbent assay for diagnosis of Epstein-Barr virus infections in childhood.
    Schaade L; Kleines M; Häusler M
    J Clin Microbiol; 2001 Nov; 39(11):3902-5. PubMed ID: 11682505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.
    Chen J; Liu T; Chen Z; Hou J; Wu Y; Li M
    Viral Immunol; 2015 Apr; 28(3):179-83. PubMed ID: 25651045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of 2 fluorescence assays for the diagnosis of Epstein-Barr virus infections].
    de Ory F; Guisasola ME
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):442-3. PubMed ID: 9887641
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies.
    Zeytinoglu A; Altuglu I; Karatas E; Yazan Sertoz R
    J Virol Methods; 2008 Mar; 148(1-2):300-2. PubMed ID: 18215427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Epstein-Barr virus-specific antibodies by an automated enzyme immunoassay. Performance evaluation and cost analysis.
    Tang YW; Helgason JA; Wold AD; Smith TF
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):549-54. PubMed ID: 9764394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS; Liao RS; Dunne WM; Gronowski AM
    J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.